홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

4,4'-디클로로-1,1'-바이페닐

4,4'-Dichlorobiphenyl

HCID 16308
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
2050-68-2
표준 SMILES
Clc1ccc(-c2ccc(Cl)cc2)cc1
InChIKey
YTBRNEUEFCNVHC-UHFFFAOYSA-N
분자식
C12H8Cl2
평균 분자량
223.09 g/mol
단동위원소 질량
222.0003056

개요

4,4'-dichlorobiphenyl is a dichlorobiphenyl carrying chloro groups at positions 4 and 4' respectively. It is a dichlorobiphenyl and a member of monochlorobenzenes.

이름 및 식별자

우선 이름
4,4'-Dichlorobiphenyl
IUPAC
1-chloro-4-(4-chlorophenyl)benzene
현지명
4,4'-디클로로-1,1'-바이페닐
영어명
4,4'-Dichlorobiphenyl
분자식
C12H8Cl2
분자량
223.1

이름 및 동의어

4,4'-Dichlorobiphenyl2050-68-24,4'-DICHLORO-1,1'-BIPHENYLp,p-Dcbpp,p'-Dichlorobiphenyl1,1'-Biphenyl, 4,4'-dichloro-PCB 151-chloro-4-(4-chlorophenyl)benzeneBiphenyl, 4,4'-dichloro-4-DCB cpdDOF6S5DT2RDTXSID0022515
이름 더 보기
4,4'-디클로로-1,1'-바이페닐pcb154,4'-CB4,4'-PCBBZ NO 15NSC 1141PCB NO 15p,p’-dcbpBALLSCHMITER NO 15
NSC-1141CHEBI:34364RefChem:53597DTXCID502515218-095-4PCB No. 15Biphenyl,4'-dichloro-4,4 inverted exclamation marka-Dichlorobiphenyl

데이터베이스 식별자

CAS
2050-68-2
PubChem CID
16308
DTXSID
DTXSID0022515
ChEMBL
CHEMBL14295
ChEBI
CHEBI:34364
UNII
DOF6S5DT2R
EC Number
218-095-4
Nikkaji
J7.868I

물성

구조 계산 물성보충 중

XLogP
5.6
극성 표면적
0 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
0
회전 가능 결합 수
1
무거운 원자 수
14
형식 전하
0
복잡도
145

실험 및 물리화학적 성질

SpringerMaterials Properties13C nuclear magnetic resonance spectrum
LogP5.23
Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section141.8 Ų [M]+ [CCS Type: TIMS, Method: calibration with PAHs]

물리화학적 성질

녹는점
288 ℃ · 288℃
끓는 점
289.78 °C · 289.78°C (rough estimate)
밀도
1.249 · 1.2490 (rough estimate)
굴절률
1.594 · 1.5940 (rough estimate)
인화점
-12 ℃ · -12℃
저장 조건
2 · 2-8°C
수용성
53 ug/L · 53ug/L(25ºC)
Henry's Law Constant
7 · 7.0×10-2 mol/(m3Pa) at 25℃, Li et al. (2003)
InChI
InChI=1S/C12H8Cl2/c13-11-5-1-9(2-6-11)10-3-7-12(14)8-4-10/h1-8H
InChIKey
YTBRNEUEFCNVHC-UHFFFAOYSA-N

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 7.1% (3 of 42) of reports.

Warning

H373 (92.9%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

P260, P273, P319, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory InformationSubstance: 4,4'-dichlorobiphenyl
Hazard Classes and CategoriesSTOT RE 2 (92.9%)

안전 및 보호

Minimum Risk LevelIntermediate Oral: 0.03 ug/kg/day (L134)

독성 정보

Treatment · 1건

There are no specific treatments for PCB poisoning, since it is not usually recognized until after substantial chronic exposure. Only preventing further exposure and treating the observed symptoms can be done. Acute inhalation can be treated by administering oxygen. (L4)

Health Effects · 1건

The most common health effects of PCBs are skin conditions such as chloracne and rashes. Chronic PCB exposure has also been shown to cause liver, stomach and kidney, damage, jaundice, edema, anemia, changes in the immune system, behavioral alterations, and impaired reproduction. (L4)

화학 및 산업

약리 정보

Metabolism/Metabolites · 2건

4,4'-Dichlorobiphenyl has known human metabolites that include 4,4-²-Dichloro-3-biphenylol.

PCBs are absorbed via inhalation, oral, and dermal routes of exposure. They are trasported in the blood, often bound to albumin. Due to their lipophilic nature they tend to accumulate in lipid-rich tissues, such as the liver, adipose, and skin. Metabolism of PCBs is very slow and varies based on the degree and position of chlorination. PCBs are metabolized by the microsomal monooxygenase system catalyzed by cytochrome P-450 enzymes to polar metabolites that can undergo conjugation with glutathione and glucuronic acid. The major metabolites are hydroxylated products which are excreted in the bile and faeces. The slow metabolism of PCBs means they tend to accumulate in body tissues. (L4, T6)

용도 및 제조

Uses · 1건

PCBs were used as coolants and lubricants in transformers, capacitors, and other electrical devices (such as fluorescent lights and refridgerators) produced before 1977. PCBs may contaminate the air and water near hazardous waste sites. In addition, PCBs bioaccumulate in the environment and may be found in fish, meat, and dairy products. (L4)

응용 분야

용도4,4''-Dichlorobiphenyl is a polychlorinated biphenyl (PCB) congeners.

상·하류 제품 정보

하류 제품

2,4'-다이클로로바이페닐

추가 설명

정의ChEBI: A dichlorobiphenyl carrying chloro groups at positions 4 and 4' respectively.

관련 반응

4건
반응 기록 만들기
HRID 268508 반응식
HRID 268508생성물로
HRID 329313 반응식
HRID 329313생성물로
HRID 1108513 반응식
HRID 1108513생성물로
HRID 2119232 반응식
HRID 2119232반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
SMILES
C1(C2=CC=C(Cl)C=C2)=CC=C(Cl)C=C1
EPA
4 · 4,4'-Dichlorobiphenyl (2050-68-2)
Exposure Routes
Oral (L4) ; inhalation (L4) ; dermal (L4)
Toxicity Summary · 1건

The mechanism of action varies with the specific PCB. Dioxin-like PCBs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic Phase I and Phase II enzymes, especially of the cytochrome P450 family. Most of the toxic effects of PCBs are believed to be results of Ah receptor binding. Other PBCs are believed to interfere with calcium channels and/or change brain dopamine levels. PCBs can also cause endocrine disurption by altering the production of thyroid hormones and binding to estrogen receptors, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. They will bioaccumulate by binding to receptor proteins such as uteroglobin. (A3, A4, A30, A66)

Signs and SymptomsChronic PCB exposure results in symptoms such as abdominal pain, nausea, vomiting, diarrhea, headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3)
Carcinogen Classification1, carcinogenic to humans. (L135)
Toxicity DataLD50: 1010 mg/kg (Oral, Rat) (T14) LD50: 880 mg/kg (Intraperitoneal, Mouse) (T14)

안전 데이터

wgk
3
rtecs
DV3912500
ridadr
2315
risk_code
11-36/37/38-22-50/53-33-67-65-38
hazard_code
F,Xi,Xn,N
safety_code
16-26-33-36-61-60-35-62
포장분류
II
위험 등급
9